Can Low Advantage Neighborhood Lead to Worse Outcomes for Kids with MS? Study Finds Out Dr. Bhumika Maikhuri30 Nov 2024 8:15 AM ISTPeople who develop multiple sclerosis (MS) as children and grow up in less advantaged neighborhoods may have a larger volume of inflammation and brain...
Dr Reddy's Laboratories Gets CDSCO Panel Nod for Marketing Approval of Siponimod Tablets Dr. Divya Colin13 Nov 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control (CDSCO) has granted marketing authorization of Dr...
Study finds certain MS therapies may not slow disability progression Dr. Kamal Kant Kohli22 Oct 2024 9:45 PM ISTIn people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened...
Medication and cognitive behavioral therapy can reduce fatigue among MS patients, finds study Dr. Kamal Kant Kohli20 Oct 2024 8:15 PM ISTIn a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two,...
Do people with multiple sclerosis have an increased risk of cancer? Dr. Kamal Kant Kohli11 Oct 2024 9:30 PM ISTA new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is...
Medical bulletin 26/ September/ 2024 Dr. Bhumika Maikhuri26 Sept 2024 3:00 PM ISTHere are the top medical news for the day:How Do Initial Symptoms of MS Have Impact on Long Run Disability?In a significant advance for multiple...
How Do Initial Symptoms of MS Impact Long-Run Disability? Study Sheds Light Dr. Bhumika Maikhuri26 Sept 2024 8:00 AM ISTIn a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and...
Roche gets USFDA nod for Ocrevus Zunovo for relapsing and progressive multiple sclerosis Ruchika Sharma19 Sept 2024 4:00 PM ISTBasel: Roche announced that the United States Food and Drug Administration (U.S. FDA) has approved OCREVUS ZUNOVO (ocrelizumab &...
Intermittent Fasting may Reduce Inflammation and improve Cognition in relapsing-remitting multiple sclerosis: Study Dr Riya Dave22 Aug 2024 11:30 PM ISTResearchers defined intermittent fasting as 500-calorie fasting twice a week and determined it to be a safe and effective dietary strategy in patients...
Use of Contraceptive Pill in nulliparous women associated with three-fold increase in Multiple Sclerosis Risk: Study Dr Riya Dave15 Aug 2024 10:30 PM ISTMultiple research analyses have been done to ascertain the possibility that oral contraceptive pills would influence the development risks of Multiple...
Multiple Sclerosis Patients on Rituximab Face Higher COVID-19 Hospitalization: Study Dr. Garima Soni10 Aug 2024 3:30 AM ISTIndia: Patients with multiple sclerosis (MS) treated with rituximab were more prone to COVID-19 infection in comparison to those treated with...
Pre-DMT Vitamin D Levels Influence MS Disease Activity and Onset, study finds Medha Baranwal25 July 2024 9:15 PM ISTItaly: The risk of disease activity in multiple sclerosis (MS) can be affected by vitamin D levels before disease-modifying treatment (DMT) starts, a...
